NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,036,000 | +2.3% | 60,589 | +0.1% | 0.45% | -5.8% |
| Q4 2018 | $1,990,000 | +23.7% | 60,549 | +83.7% | 0.48% | +55.0% |
| Q2 2018 | $1,609,000 | -88.8% | 32,960 | -75.6% | 0.31% | -88.4% |
| Q1 2018 | $14,378,000 | +263.7% | 135,312 | +104.4% | 2.67% | +226.0% |
| Q4 2017 | $3,953,000 | +25.0% | 66,200 | -49.8% | 0.82% | -6.9% |
| Q3 2017 | $3,162,000 | +29.7% | 131,757 | +5.7% | 0.88% | +22.4% |
| Q2 2017 | $2,437,000 | -40.8% | 124,632 | -28.9% | 0.72% | -30.0% |
| Q1 2017 | $4,115,000 | – | 175,315 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |